Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-13 Singer Michael Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +11,316.26 11,316.26
2023-11-13 Singer Michael Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +1,672.39 1,672.39
2023-11-13 Singer Michael Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +210.15 210.15
2023-11-13 Singer Michael Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +2,837.05 2,837.05
2023-11-13 Singer Michael Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +2,837.05 2,837.05
2023-11-13 Singer Michael Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +436.07 436.07
2023-11-13 Kalayoglu Murat Director Grant or award +257,739 257,739
2023-11-13 Kalayoglu Murat Director Other acquisition +3,303,699 3,303,699
2023-11-13 Kalayoglu Murat Director Grant or award · Series A Non-Voting Convertible Preferred Stock +14,755.61 14,755.61
2023-11-13 Kalayoglu Murat Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +189,136.77 189,136.77
2023-11-13 Kalayoglu Murat Director Purchase · Series A Non-Voting Convertible Preferred Stock +619.63 $249,999.98 $154.9M 619.63
2023-11-13 Miljkovic Milos Chief Medical Officer Grant or award · Stock Option (Right to Buy) +2,565.87 2,565.87
2023-09-25 Brunn Carsten President and CEO Sale −2,932 $1.06 $3K 783,081
2023-09-25 TRABER PETER G Chief Medical Officer Sale −705 $1.06 $747 451,826
2023-05-31 Kishimoto Takashi Kei Chief Scientific Officer Gift −26,500 251,816
2023-05-31 Kishimoto Takashi Kei Chief Scientific Officer Gift −26,500 225,316
2023-05-30 Kishimoto Takashi Kei Chief Scientific Officer Gift −43,000 321,316
2023-05-30 Kishimoto Takashi Kei Chief Scientific Officer Gift −43,000 278,316
2023-01-05 Brunn Carsten President and CEO Sale −13,396 $1.13 $15K 786,090
2023-01-05 Brunn Carsten President and CEO Sale −77 $1.12 $86 786,013

Page 18 of 25 · 495 trades